The Lead Role for WRAP53β: Scaffolding Rna-Protein Complexes {#s1}
============================================================

Function Through Organization
-----------------------------

Structural organization within the nuclear space contributes significantly to functional regulation (Misteli, [@B62]; Nunez et al., [@B69]; Van Bortle and Corces, [@B101]). For example, organizing appropriate ribonucleoprotein complexes into the nuclear organelles known as Cajal bodies controls and accelerates reactions involved in pre-mRNA splicing and telomere elongation (Carmo-Fonseca et al., [@B10]; Jády et al., [@B43]; Kiss et al., [@B46]; Matera and Shpargel, [@B58]; Stanek and Neugebauer, [@B94]). Similarly, upon DNA damage, repair factors are concentrated into foci, providing an environment beneficial for repair (Bekker-Jensen et al., [@B6]; Altmeyer et al., [@B2]).

Cajal bodies contain transcription factors and polymerases (Polak et al., [@B76]; Machyna et al., [@B52]; Hutten et al., [@B42]) and like other nuclear bodies, can be formed in association with transcription (Shevtsov and Dundr, [@B85]). For Cajal bodies, this nucleation occurs at specific genomic loci, including genes encoding small nuclear (sn)RNAs, small nucleolar (sno)RNAs, small Cajal body-specific (sca)RNAs and histones (Frey and Matera, [@B26], [@B27]; Smith et al., [@B88]; Machyna et al., [@B52]). When transcribed, these loci are brought together in a transcriptional center within the Cajal body that accelerates RNA production (Sawyer et al., [@B82],[@B83]; Wang et al., [@B105]). The RNAs transcribed are subsequently processed, modified (methylated, pseudouridinylated) and/or function within the Cajal bodies themselves (Darzacq et al., [@B18]; Jády et al., [@B44]; Dominski and Marzluff, [@B21]; Enwerem et al., [@B22]). Similarly, RNAs are transcribed from sites of DNA damage (Francia et al., [@B25]; Wei et al., [@B108]; Michelini et al., [@B61]; Bonath et al., [@B7]), which can hybridize with the damaged DNA (Ohle et al., [@B70]; Lu et al., [@B49]), be processed by DICER and DROSHA (Francia et al., [@B25]; Michelini et al., [@B61]; Lu et al., [@B49]) or become methylated by METTL3 (Xiang et al., [@B111]), thereafter, regulating damage repair.

The Genome and Cajal Bodies Come Together With WRAP53β
------------------------------------------------------

The scaffold protein WRAP53β (WD40-encoding RNA antisense to p53) (alias WRAP53, WDR79, and TCAB1), initially discovered in our laboratory as an antisense gene to p53 (Mahmoudi et al., [@B53]), plays several key roles in Cajal bodies. First, this protein is vital for their formation (Mahmoudi et al., [@B55]), bringing the necessary proteins and gene loci into close proximity (Mahmoudi et al., [@B55]; Wang et al., [@B105]). Loss of WRAP53β disrupts Cajal bodies, suppresses clustering of sn/sno/scaRNA/histone loci and downregulates transcription from these sites. Second, WRAP53β plays essential roles in maintaining Cajal bodies and targeting factors to these organelles ([Figure 1A](#F1){ref-type="fig"}; Mahmoudi et al., [@B55]; Henriksson and Farnebo, [@B38]), probably by stabilizing interactions between Cajal body components. The direct interaction between the Cajal body marker Coilin and the splicing-related survival of motor neuron (SMN) protein is stabilized by WRAP53β (Mahmoudi et al., [@B55]), which can bind several proteins and RNAs simultaneously through its seven WD40 repeats ([Figures 1A,B](#F1){ref-type="fig"}). WRAP53β also binds the telomerase RNA (TERC) and locates the telomerase complex to Cajal bodies and further on to telomeres (Venteicher et al., [@B102]).

![**(A)** Schematic illustration of the different WRAP53β complexes, their localization and function. Note: scaRNA and TERC are RNA molecules. **(B)** Schematic illustration of the domains, binding, phosphorylation and ubiquitination sites in the WRAP53β protein. The sites for post-translational modifications were obtained from PhosphoSitePlus on April 17, 2019. The location of WD40 repeats were predicted using the WD40-repeat protein Structures Predictor (Wu et al., [@B110]; Wang et al., [@B107], [@B106]; Ma et al., [@B51]); (WDSP, May 2nd 2019): WD40 1 (amino acid residues 159--197), WD40 2 (residues 207--259), WD40 3 (residues 266--305), WD40 4 (residues 313--354), WD40 5 (residues 358--397), WD40 6 (residues 402--442), WD40 7 (residues 450--510). **(C)** Schematic view of the functions of WRAP53β in Cajal bodies, at the break site and in surrounding chromatin. Ubiquitin-dependent recruitment of DNA repair factors occurs at regions flanking the break site. WRAP53β binds γH2AX and also scaffolds the interaction between MDC1 and RNF8, which is important for the recruitment of RNF8 to DNA breaks. Once there, RNF8 and RNF168 ubiquitinate proteins at damaged chromatin, which stimulates recruitment of downstream factors 53BP1, RAD51, and BRCA1. BRCA1 forms several sub-complexes with different functions, of which the BRCA1-A complex (containing BRCA1, RAP80, BRCC36, and additional proteins not discussed here) restrict resection. Recruitment to the break site appears to be ubiquitin-independent and the factors recruited here include XRCC4, which promotes NHEJ, or DNA break sensor proteins, such as the MRN complex that promote HR. Pools of WRAP53β and BRCA1 also locate at this site for reasons unknown. Functions performed by WRAP53β in Cajal bodies could potentially be performed at break sites. The recruitment of RAD51, a downstream protein of WRAP53β, to DNA lesions appears to occur via both ubiquitin-dependent and independent mechanisms.](fmolb-06-00051-g0001){#F1}

Extensively interacting chromosomal loci are often fragile and enriched in DNA repair factors, indicating that they are primed for rapid DNA repair (Sobhy et al., [@B91]). WRAP53β is involved in DNA repair and its presence at Cajal body-associated gene loci may thus allow rapid repair. In addition, assembly of WRAP53β at DNA lesions may facilitate damage-induced genome reorganization and/or clustering of DNA breaks, which promotes efficient recognition and repair of lesions (Aymard et al., [@B3]; Stadler and Richly, [@B93]). WRAP53β may also stimulate transcription of RNA from the break site and/or its processing or concentrate repair factors into specialized foci to accelerate necessary reactions.

Spotlight on Dna Repair: WRAP53β Controls Local Ubiquitination {#s2}
==============================================================

Regulation of Protein Recruitment and Repair Pathway Choice by Ubiquitination
-----------------------------------------------------------------------------

Among the most toxic DNA lesions are double-strand breaks, repaired either by non-homologous end joining (NHEJ) or homologous recombination (HR) (reviewed e.g., by Ciccia and Elledge, [@B15]; Ceccaldi et al., [@B11]). Following such breakage, the damaged chromatin is modified chemically, including by ubiquitination, which facilitates recruitment of repair factors. Ubiquitination involves stepwise enzymatic activation, conjugation, and ligation of the small ubiquitin protein to lysine residues by E1, E2, and E3 enzymes, respectively (Pickart and Eddins, [@B75]). The presence of lysine residues in ubiquitin itself allows formation of various types of polyubiquitin chains, with ubiquitin chains linked at K48 typically targeting proteins for degradation, whereas K63-linked chains often signal protein recruitment (Panier and Durocher, [@B72]; Smeenk and van Attikum, [@B87]).

RNF8, the first ubiquitin ligase to arrive at DNA breaks (Huen et al., [@B41]; Kolas et al., [@B47]; Mailand et al., [@B56]), initially catalyzes K63-linked ubiquitin chains on histone H1 (Thorslund et al., [@B99]), which recruits RNF168 to ubiquitinate histone H2A at K13/K15 (Mattiroli et al., [@B60]; Uckelmann and Sixma, [@B100]), thereby potentiating the local ubiquitin signal (Uckelmann and Sixma, [@B100]). This triggers recruitment of 53BP1 (via K15 ubiquitination of H2A), which then restricts DNA end resection and promotes NHEJ repair ([Figure 1C](#F1){ref-type="fig"}; Nakamura et al., [@B67]; Kolas et al., [@B47]; Fradet-Turcotte et al., [@B24]). Intriguingly, ubiquitin chains also recruit RAP80 along with the key HR factor BRCA1 (Sobhian et al., [@B90]; Wang and Elledge, [@B103]).

The choice of repair pathway beyond this point remains unknown. In addition to the known determinants \[i.e., cell cycle phase, site of damage (e.g., gene-rich/poor regions) and local concentration of factors required\], the BRCA1 recruited to ubiquitin as part of the BRCA1-A complex appears to be involved in fine-tuning the choice of repair pathway, since this complex attenuates end resection ([Figure 1C](#F1){ref-type="fig"}; Sobhian et al., [@B90]; Wang and Elledge, [@B103]; Hu et al., [@B40]). In contrast, BRCA1 recruited via resected DNA belonging to other complexes (i.e., BRCA1-B, BRCA1-C, BRCA1-D) promotes end resection, strand invasion and RAD51 loading, crucial steps in the HR pathway (Greenberg et al., [@B34]; Sy et al., [@B98]; Zhang et al., [@B115]; Xie et al., [@B112]; Cruz-García et al., [@B17]; Savage and Harkin, [@B81]; Zhao et al., [@B117]). Moreover, BRCA1 has E3 ligase activity and, with the E3 ligase BARD1, can ubiquitinate H2A to remove 53BP1, thereby promoting HR (Densham et al., [@B19]).

Other ubiquitin ligases also promote HR and influence NHEJ by fine-tuning ubiquitination of damaged chromatin. For example RNF20 and RNF40 ubiquitinate histone H2B (Moyal et al., [@B64]; Nakamura et al., [@B66]; So et al., [@B89]), while UBE4A edits ubiquitin chains at breaks (Baranes-Bachar et al., [@B4]).

Deubiquitinating enzymes (DUBs) are also involved in the choice of repair pathway. Thus, removal of ubiquitin chains by POH1 promotes HR by displacing 53BP1 and RAP80 to the periphery of the repair foci (Butler et al., [@B9]; Kakarougkas et al., [@B45]; Nakada, [@B65]). Some BRCA1 complexes contain DUBs, including BRCC36, which functions together with the BRCA1-A complex; removal of this DUB results in unrestrained end resection and hyperactive HR ([Figure 1C](#F1){ref-type="fig"}; Shao et al., [@B84]; Ng et al., [@B68]).

These observations emphasize the central role of ubiquitination in the DNA damage response, in which the RNF8/RNF168-pathway is a key upstream actor, regulating several steps of both NHEJ and HR repair. Notably, the RNF8 protein is unstable, so continuous splicing is required for its presence at DNA lesions (Pederiva et al., [@B74]). Consequently, even short term inhibition of splicing impairs repair (Pederiva et al., [@B74]), which can explain the defective repair associated with knockdown of various splicing factors detected in several genome-wide siRNA screens (Paulsen et al., [@B73]; Adamson et al., [@B1]).

Alteration of Chromatin Structure by Ubiquitination
---------------------------------------------------

The structure of chromatin around DNA lesions influences the DNA damage response. Initial compaction stimulates early steps in this process, such as recruitment of the MRN complex, while persistent compaction is unfavorable to downstream repair and recovery, and attenuates phosphorylation of CHK2 (Burgess et al., [@B8]). Moreover, a collar of compact chromatin is formed around the DNA lesions, potentially to restrict repair to this site, since repair factors, including 53BP1, only localize within its decompacted interior (Lou et al., [@B48]).

Interestingly, this compaction around the break site is dependent on RNF8 (Lou et al., [@B48]), indicating a role for ubiquitination in regulating the higher-order structure of damaged chromatin. Since RNF8 can promote relaxation of chromatin by recruiting the remodeling factor CHD4 (Luijsterburg et al., [@B50]), it is possible that interior decondensation by RNF8 triggers the formation of a heterochromatic border around DNA breaks. Altogether, the ubiquitin response not only stimulates recruitment of repair factors and influences the choice of DNA double-strand break repair pathway but also appears to shape the local chromatin for proper progression of the DNA damage response.

WRAP53β Orchestrates Ubiquitination of Damaged Chromatin via RNF8
-----------------------------------------------------------------

WRAP53β was first implicated in DNA repair by several screens for novel repair proteins (Matsuoka et al., [@B59]; Paulsen et al., [@B73]; Adamson et al., [@B1]). Its direct involvement in the repair of DNA double-strand breaks by both HR and NHEJ was later confirmed and shown to involve scaffolding interactions between RNF8 and MDC1 (Henriksson et al., [@B39]) by simultaneously and independently binding the FHA domains of both proteins through its own WD40 domain ([Figure 1B](#F1){ref-type="fig"}; Henriksson et al., [@B39]). In this manner, WRAP53β promotes assembly of RNF8 at DNA lesions, ubiquitination of damaged chromatin and downstream recruitment of 53BP1, BRCA1, and RAD51 ([Figure 1A](#F1){ref-type="fig"}; Henriksson et al., [@B39]; Hedström et al., [@B37]). RNF8 and MDC1 can interact directly, but do not in the absence of WRAP53β, which appears to stabilize their interaction in a manner similar to the SMN-coilin interaction ([Figure 1A](#F1){ref-type="fig"}). WRAP53β does not influences RNF8 levels, excluding indirect effects on splicing.

Behind the Scenes: WRAP53β Plays Multiple Roles at Dna Breaks {#s3}
=============================================================

WRAP53β Influences DNA Repair Beyond RNF8
-----------------------------------------

Notably, depletion of WRAP53β reduces HR and NHEJ efficiency more than knockdown of RNF8 (Henriksson et al., [@B39]), indicating that WRAP53β plays additional roles, probably ubiquitin-independent, in DNA repair. Indeed, two distinct WRAP53β fractions are present at DNA double-strand breaks; one in regions surrounding the break (also positive for γH2AX/MDC1/RNF8) and another at the break site itself \[normally devoid of/low in γH2AX/MDC1/RNF8 (Henriksson et al., [@B39]; Goldstein and Kastan, [@B32]), but instead enriched in NHEJ factors (e.g., XRCC4) and DNA break sensors (e.g., NBS1, part of the MRN complex) (Goldstein et al., [@B31])\]. WRAP53β is recruited to the break site itself more rapidly and remains there longer than in the surrounding regions ([Figure 1C](#F1){ref-type="fig"}; Henriksson et al., [@B39]).

Interestingly, like WRAP53β, BRCA1 is recruited to both regions and to a higher extent to the break site. Its recruitment to the surrounding regions depends on the RNF8/RNF168/RAP80-pathway (and on ATM and PARP), while its accumulation at the break site is mediated by the MRN complex. BRCA1 appears to stimulate cell cycle checkpoints at the flanking regions and re-ligation of the breaks at the break site (Xu et al., [@B113]; Goldstein and Kastan, [@B32]). Thus, WRAP53β and BRCA1 both participate in the RNF8-mediated ubiquitination pathway, while promoting other aspects of repair at the break site itself ([Figure 1C](#F1){ref-type="fig"}).

What Regulates WRAP53β?
-----------------------

Recruitment of WRAP53β to repair foci, probably the regions surrounding DNA double-strand breaks, requires ATM, H2AX and MDC1 (Henriksson et al., [@B39]). Importantly, upon DNA damage, WRAP53β is phosphorylated by ATM at serine 64 (Matsuoka et al., [@B59]; Coucoravas et al., [@B16]) and a phosphomutant of WRAP53β (S64A) cannot rescue defects in DNA repair when the wild-type protein is knocked down (Rassoolzadeh et al., [@B80]; Coucoravas et al., [@B16]). ATM-mediated phosphorylation of WRAP53β does not influence its interaction with RNF8 and MDC1. However, WRAP53β also binds γH2AX and this interaction is enhanced by phosphorylation ([Figure 1B](#F1){ref-type="fig"}; Rassoolzadeh et al., [@B80]; Coucoravas et al., [@B16]). Since WRAP53β binds RNF8 and MDC1 even before damage, these three proteins might pre-form a complex that can be activated and recruited to DNA breaks by ATM in a multistep manner, e.g., phosphorylation of MDC1 allows direct RNF8-MDC1 interaction, phosphorylation of WRAP53β stimulates WRAP53β-γH2AX interaction and phosphorylation of γH2AX allows MDC1-γH2AX interaction (Rassoolzadeh et al., [@B80]; Coucoravas et al., [@B16]).

Phosphorylated WRAP53β^S64^ locates to both DNA breaks and Cajal bodies. However, the unphosphorylated form accumulates in Cajal bodies to a greater extent (Coucoravas et al., [@B16]), indicating that phosphorylation of WRAP53β by ATM relocates this protein from Cajal bodies to DNA breaks. WRAP53β targets several factors to Cajal bodies and maintains the structure of this organelle and these functions may be affected by WRAP53β relocation. For example, ionizing radiation moves WRAP53β to DNA breaks, while telomerase (Wong et al., [@B109]) and several other Cajal body components (including coilin, SMN, fibrillarin, and snRNAs) move to and around nucleoli (in nucleolar caps). This indicates that exit of WRAP53β from Cajal bodies displaces associated proteins to other sites. Moreover, Cajal bodies become disrupted several hours after DNA damage (Gilder et al., [@B30]).

In addition to S64, 23 other residues of WRAP53β are phosphorylated and four ubiquitinated by unknown enzymes for unclear reason ([Figure 1B](#F1){ref-type="fig"}) (data from UniProt and PhosphoSitePlus websites) (Hebert and Poole, [@B36]). WRAP53β appears to be rate-limiting for both HR and NHEJ and, accordingly, its overexpression enhances the efficiency of both pathways by stimulating RNF8-mediated ubiquitination at damaged chromatin (Rassoolzadeh et al., [@B79]). Further studies on the complex interplay between the functions of WRAP53β in DNA repair, the Cajal body and telomere maintenance are required and post-translational modifications may be important in this context.

WRAP53β Acting Off-Script: Loss of Tumor Suppression and Activation of the Dna Damage Response In Cancer {#s4}
========================================================================================================

Loss of Tumor Suppression by WRAP53β
------------------------------------

Inactivating germline mutations in WRAP53β cause dyskeratosis congenita, characterized by bone marrow failure, premature aging and predisposition for cancer (Zhong et al., [@B118]). Moreover, downregulation of WRAP53β RNA or its loss from the nucleus in patients with head and neck, breast, and ovarian cancer is correlated with shorter survival (Garvin et al., [@B29]; Hedström et al., [@B37]; Silwal-Pandit et al., [@B86]). Furthermore, numerous genetic alterations in *WRAP53*, mainly deletions or mutations, are present in multiple cancers ([Figure 2A](#F2){ref-type="fig"}) (cBioPortal, <https://www.cbioportal.org/>) (Cerami et al., [@B12]; Gao et al., [@B28]), further evidence that loss-of-WRAP53β-function promotes cancer development/progression. In addition, attenuated expression of WRAP53β correlates with resistance of patients with head and neck cancer and metastasized rectal cancer to radiotherapy (Zhang et al., [@B116]; Garvin et al., [@B29]).

![**(A)** The frequency of genetic alterations in *WRAP53* associated with various cancer types (minimum threshold of 2%) (From cBioPortal, accessed April 17, 2019). The numbers in parenthesis represent the number of patients analyzed. **(B)** Proposed model for the involvement of WRAP53β and the DNA damage response in the development of cancer. Aberrant cell proliferation may cause replication stress, formation of DNA double-strand breaks and activation of the DNA damage response. Overexpression of WRAP53β as part of the response stimulates repair, growth arrest and/or apoptosis, but some damaged cells may escape (e.g., due to downregulation of WRAP53β), leading to genomic instability and potential progression into cancer.](fmolb-06-00051-g0002){#F2}

At the same time, WRAP53β is overexpressed in other cancer types (see further below), but the clinical relevance remains unclear. Although we have suggested that WRAP53β has oncogenic properties (Mahmoudi et al., [@B54]), we now believe that this is a misinterpretation of the data, which instead reflects participation of WRAP53β in the DNA damage response ([Figure 2B](#F2){ref-type="fig"}).

Does WRAP53β Appear to be Oncogenic by Activating the DNA Damage Response?
--------------------------------------------------------------------------

Precancerous lesions are characterized by activation of DNA damage signaling and repair, often due to replication stress, which is believed to constrain tumor progression. This phenomenon includes formation of 53BP1 foci and activation of the ATM/ATR checkpoint; premalignant tumor samples stain positively for the phosphorylated forms of ATM, CHK1, CHK2, RAD17, p53, and H2AX (Bartkova et al., [@B5]; Gorgoulis et al., [@B33]). Potential inactivating mutations in key DNA damage response proteins, such as p53 and ATM (Olivier et al., [@B71]; Choi et al., [@B14]) allow survival of damaged and genetically unstable cells that upon clonal expansion progress into carcinoma (Bartkova et al., [@B5]; Gorgoulis et al., [@B33]).

WRAP53β is overexpressed in a variety of cancer cell lines and primary head and neck, lung and colorectal cancers (Zhang et al., [@B116]; Rao et al., [@B78]; Sun et al., [@B95], [@B97]; Zhu et al., [@B119]). In addition, knockdown of this protein promotes apoptosis and reduces proliferation of cancer cell lines and xenografts (Mahmoudi et al., [@B54]; Sun et al., [@B95], [@B97]; Wang et al., [@B104]; Yuan et al., [@B114]; Chen et al., [@B13]; Zhu et al., [@B119]). Such observations appeared to indicate that WRAP53β may act as an oncogene. However, in the vast majority of studies to date overexpression of WRAP53β was not significantly associated with worse patient survival.

Instead, overexpression of WRAP53β may reflect its involvement in DNA repair and thus be a response to the stress of rapid proliferation. Further support for this proposal includes the following: (1) upregulation of WRAP53β promotes activation of the ATR-CHK1 pathway in nasopharyngeal carcinoma induced by Epstein Barr Virus (Wang et al., [@B104]); (2) upregulation of WRAP53β correlates with activation of the DNA damage response pathway in ovarian cancer (Hedström et al., [@B37]); (3) subsequent downregulation of WRAP53β in patients with ovarian cancer is significantly associated with higher mortality, while intitial upregulation was not, indicating that downregulation drives tumor progression (Hedström et al., [@B37]); and (4) similarly, downregulation of WRAP53β in patients with metastasized rectal cancer promotes resistance to radiotherapy and is associated with higher mortality, while initial upregulation did not influence patient survival (Zhang et al., [@B116]). Moreover, enhanced expression of WRAP53β in cancer cells may be linked to their greater number of Cajal bodies, reflecting a higher demand for associated functions (Spector et al., [@B92]).

Potential re-activation of telomerase is, as far as we can see, the only reasonable mechanism by which upregulation of WRAP53β could actually promote tumorigenesis. However, the telomerase gene is not an oncogene, since its product does not by itself cause uncontrolled growth and is active in normal embryonic stem and germline cells (Harley, [@B35]). Several studies have reported a correlation between overexpression of WRAP53β and increased telomere length or telomerase activity, but it remains to be determined whether telomerase activity is correlated with prognosis (Qiu et al., [@B77]; Wang et al., [@B104]; Sun et al., [@B96]).

Concluding Remarks---Wrapping it all up {#s5}
=======================================

The scaffolding protein WRAP53β organizes the genome so that formation of Cajal bodies is stimulated, the expression of associated genes enhanced and their products concentrated in these organelles. Similarly, WRAP53β concentrates factors important for repair of DNA double-strand breaks via ubiquitination of damaged chromatin. Upon DNA damage, a fraction of WRAP53β is phosphorylated, promoting its role in DNA repair, with several other pools of WRAP53β having different localizations and functions, orchestrated by various post-translational modifications. This complexity explains how this protein performs so many tasks within the cell in a coordinated fashion, as well as why disease may occur when it is lost or dysfunctional.

In addition to dyskeratosis congenita and sporadic cancer, loss of WRAP53β has been linked to the pathogenesis of spinal muscular atrophy (Mahmoudi et al., [@B55]; Di Giorgio et al., [@B20]). Furthermore, this protein is part of a repair machinery that organizes and resolves persistent DNA damage in neurons (Mata-Garrido et al., [@B57]) and accumulation of such damage is believed to contribute to neurodegenerative disorders such as spinal muscular atrophy and amyotrophic lateral sclerosis (Fayzullina and Martin, [@B23]; Mitra et al., [@B63]).

Thus, more in-depth understanding of the role of WRAP53β in DNA repair and other processes may help decipher the complicated mechanisms underlying tumorigenesis, premature aging and neurodegeneration and thereby lead to novel treatment strategies.
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:   BRCA1/BRCA2-containing complex subunit 36
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:   Deubiquitinating enzyme
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:   Histone 1
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H2B

:   Histone 2B

H2AX
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:   RAD50 double strand break repair protein and Nibrin

NBS1

:   Nibrin

NHEJ

:   Non-homologous end joining

PARP

:   Poly (ADP-ribose) polymerase

POH1
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RAD17

:   DNA repair protein RAD17 homolog

RAD51

:   DNA repair protein RAD51 homolog

RAP80

:   Receptor-associated protein 80
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:   Ring finger protein 8

RNF20

:   Ring finger protein 20

RNF40
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:   Ring finger protein 168

scaRNA
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:   Small nuclear RNA
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:   Small nucleolar RNA
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XRCC4

:   X-ray repair cross-complementing protein 4.
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